Fred M. Teskin

Array ( [id] => 10822079 [patent_doc_number] => 20160168243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Antagonists to IL-6 to Raise Albumin and/or Lower CRP' [patent_app_type] => utility [patent_app_number] => 14/968098 [patent_app_country] => US [patent_app_date] => 2015-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 90603 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14968098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820483 [patent_doc_number] => 20160166647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Pegylated Interleukin-10' [patent_app_type] => utility [patent_app_number] => 14/965607 [patent_app_country] => US [patent_app_date] => 2015-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8065 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11851665 [patent_doc_number] => 20170226157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 15/326512 [patent_app_country] => US [patent_app_date] => 2015-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12333 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13461707 [patent_doc_number] => 20180282396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/532097 [patent_app_country] => US [patent_app_date] => 2015-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737295 [patent_doc_number] => 20160083445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'NOVEL POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/953759 [patent_app_country] => US [patent_app_date] => 2015-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25562 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14953759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12343620 [patent_doc_number] => 09950037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-24 [patent_title] => Enhancing progenitor cell numbers [patent_app_type] => utility [patent_app_number] => 14/947722 [patent_app_country] => US [patent_app_date] => 2015-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 9625 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14947722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13093371 [patent_doc_number] => 10066017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist [patent_app_type] => utility [patent_app_number] => 14/940431 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 36 [patent_no_of_words] => 39326 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14940431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12346902 [patent_doc_number] => 09951137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-24 [patent_title] => ST2L antagonists and methods of use [patent_app_type] => utility [patent_app_number] => 14/939624 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25093 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14939624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822077 [patent_doc_number] => 20160168242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/937778 [patent_app_country] => US [patent_app_date] => 2015-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 110 [patent_figures_cnt] => 110 [patent_no_of_words] => 99328 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 69 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13154039 [patent_doc_number] => 10093732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Antagonists of IL-6 to prevent or treat thrombosis [patent_app_type] => utility [patent_app_number] => 14/933141 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 56 [patent_no_of_words] => 99052 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774793 [patent_doc_number] => 20160120949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'USES OF IL-12 IN HEMATOPOIETIC IMMUNOTHERAPY (HIT)' [patent_app_type] => utility [patent_app_number] => 14/928499 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22861 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14928499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693732 [patent_doc_number] => 20160039878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof' [patent_app_type] => utility [patent_app_number] => 14/922630 [patent_app_country] => US [patent_app_date] => 2015-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 41556 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14594187 [patent_doc_number] => 10350270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Interleukin-15 compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 15/513820 [patent_app_country] => US [patent_app_date] => 2015-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35292 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12086838 [patent_doc_number] => 09840558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'Human antibody specific for interleukin-1alpha' [patent_app_type] => utility [patent_app_number] => 14/877964 [patent_app_country] => US [patent_app_date] => 2015-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7775 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13049307 [patent_doc_number] => 10046030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Compositions and methods for preventing and treating infection [patent_app_type] => utility [patent_app_number] => 15/517191 [patent_app_country] => US [patent_app_date] => 2015-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 20887 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10670883 [patent_doc_number] => 20160017028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component' [patent_app_type] => utility [patent_app_number] => 14/873861 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24015 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11612592 [patent_doc_number] => 09650439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory' [patent_app_type] => utility [patent_app_number] => 14/859872 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 38 [patent_no_of_words] => 59238 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14948411 [patent_doc_number] => 10435464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-10-08 [patent_title] => Methods for making recombinant proteins [patent_app_type] => utility [patent_app_number] => 14/845440 [patent_app_country] => US [patent_app_date] => 2015-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 37032 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13079411 [patent_doc_number] => 10059763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Compound targeting IL-23A and TNF-alpha and uses thereof [patent_app_type] => utility [patent_app_number] => 14/844338 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 27634 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 436 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13648009 [patent_doc_number] => 09850310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => CD123 binding agents and uses thereof [patent_app_type] => utility [patent_app_number] => 14/844194 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 68 [patent_no_of_words] => 53533 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844194 [rel_patent_id] =>[rel_patent_doc_number] =>)